GbS Global Biopharma ("GbS"), the wholly-owned Canadian subsidiary of GB Sciences, Inc. (OTCQB: GBLX), is a plant-based research and biopharma drug development company. Their goal is to create patented formulations of plant-inspired, optimized therapeutic mixtures (OTM) for the prescription drug market to treat a variety of conditions.

Biotechnology

GbS Global Biopharma

John Clayborn Poss

Zach Swarts

Michael Farley

Andrea Small-Howard

GbS Global Biopharma's Leadership Team includes Zach Swarts and 1 others.

Leadership Team

About

Team members